Sarcoma D012509

Description

A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.   MeSH

Hierarchy View

Subtype Terms (23)

Adenosarcoma
3 approved drugs

Carcinosarcoma
12 drugs (8 approved, 4 experimental)

Chondrosarcoma
52 drugs (33 approved, 19 experimental)

Desmoplastic Small Round Cell Tumor
35 drugs (25 approved, 10 experimental)

Endometrial Stromal Tumors
1 approved drug

Fibrosarcoma
34 drugs (24 approved, 10 experimental)

Hemangiosarcoma
31 drugs (20 approved, 11 experimental)

Histiocytoma, Malignant Fibrous
3 drugs (2 approved, 1 experimental)

Leiomyosarcoma
74 drugs (45 approved, 29 experimental)

Liposarcoma
71 drugs (42 approved, 29 experimental)

Lymphangiosarcoma
2 approved drugs

Mixed Tumor, Mesodermal
2 approved drugs

Myosarcoma
2 approved drugs

Myxosarcoma
 

Osteosarcoma
175 drugs (94 approved, 81 experimental)

Phyllodes Tumor
 

Sarcoma, Alveolar Soft Part
17 drugs (13 approved, 4 experimental)

Sarcoma, Clear Cell
33 drugs (22 approved, 11 experimental)

Sarcoma, Experimental
 

Sarcoma, Kaposi
73 drugs (51 approved, 22 experimental)

Sarcoma, Myeloid
35 drugs (28 approved, 7 experimental)

Sarcoma, Small Cell
 

Sarcoma, Synovial
61 drugs (31 approved, 30 experimental)


Phase 2 Indicated Drugs (206)

Phase 1 Indicated Drugs (137)


Organization Involved with Phase 3 Indications (107)

Organization Involved with Phase 2 Indications (274)

1 Million 4 Anna Foundation

Aadi, LLC

Adaptimmune

Adolescent and Young Adult (AYA) Cancer Program

AEterna Zentaris

Agenus Inc.

AGO Germany

Agouron

AIDS and Cancer Specimen Resource

AIDS Healthcare Foundation

Ain Shams University

AIO-Studien-gGmbH

Aix-University of Marseille

Amgen

Anderson Clinical Research

Apexigen, Inc.

Apogee Biotechnology Corporation

Arbeitsgemeinschaft fur Internistische Onkologie (AIO)

Arnold Palmer Hospital for Children

ArQule

ASO SS Antonio e Biagio e C Arrigo Alessandria, Italy

Assistance Publique - Hôpitaux de Paris

Astellas

Astex Pharmaceuticals, Inc.

AstraZeneca

Australasian Sarcoma Study Group

Autonomous University of Madrid

AVEO Pharmaceuticals

Baker Norton Pharmaceuticals

Bankura Sammilani Medical College

Bayer

Baylor University

BioAtla, LLC

BioInvent International AB

Boehringer Ingelheim

Bristol-Myers Squibb

Burzynski Research Institute

Campus Biomedico of Rome

Cancer Immunotherapy Trials Network

Cancer Research UK

Cancer Treatment Research Foundation

Cantonal Hospital of St. Gallen

Carson Sarcoma Foundation

Case Western Reserve University

Celgene

Central South University

Centre Leon Berard

Chao Family Comprehensive Cancer Center

ChemoWarrior: the eli sidler foundation

Children's National Medical Center

China Medical University

Christian Albrechts University

City of Hope National Medical Center

Clinical Solutions

Columbia University

Cyteir Therapeutics, Inc.

Daiichi Sankyo

Dalian Medical University

Daqing Oil Field Hospital

Department of Defense

Deutsche Krebshilfe e.V.

Eleison Pharmaceuticals

Enzon

Epeius Biotechnologies

Esperas Pharma Inc.

European Commission

Exelixis

FeRx

Florida International University

Fondation ARC

Fondazione del Piemonte IRCCS di Candiolo

French Sarcoma Group

Fudan University

Gansu Provincial Hospital

Gem Pharmaceuticals

Genentech

General Electric

Genor BioPharma Co., Ltd.

Genzyme

German Cancer Research Center

German Sarcoma Group

Gottfried Wilhelm Leibniz Universität Hannover

Government of France

Government of Mexico

Government of Singapore

Government of Taiwan

Hangzhou Third Hospital

Harbin Medical University

Hebrew University

Hengrui Therapeutics, Inc.

Herbert Irving Comprehensive Cancer Center

Hoosier Cancer Research Network

Hospital A.C. Camargo

Hospital Santa Marcelina, Sao Paulo, Brasil

Hospital Universitario Central de Asturias

Hospital Universitario Niño Jesús

Huazhong University of Science and Technology

Icahn School of Medicine at Mount Sinai

Ignyta, Inc.

Imclone

Immunovative Therapies

Incyte

Inex Pharmaceuticals

Instituto Nacional de Enfermedades Respiratorias

Iovance

i-ROK Foundation

Istituto Clinico Humanitas - Rozzano (MI), Italy

Istituto Nazionale per lo Studio e la Cura dei Tumori

Istituto Superiore di Sanità

Janssen Pharmaceutica NV

Jiangsu Cancer Institute & Hospital

Jiao Tong University

Jilin University

Jinan University

Johannes Gutenburg University

Johns Hopkins University

Joseph Ahmed Foundation (JAF)

J. W. Goethe University

Katholieke Universiteit Leuven

KK Women's and Children's Hospital

Korea University

Lederle

Liaoning Province Tumor Hospital

Ligand Pharmaceuticals

Louisiana State University

Loxo Oncology

Ludwig Institute for Cancer Research

Lytix Biopharma AS

MabVax Therapeutics, Inc.

Mackay Medical College

Maria Sklodowska Curie Children's Hospital

McGill University

Medarex

Medical College of Wisconsin

Medical University of Graz

Medical University of South Carolina

Medical University of Vienna

MedImmune

Memorial Sloan-Kettering Cancer Center

Mercer University

Merck KGaA

Merck Serono

Mirati Therapeutics Inc.

MolMed S.p.A.

Morphotek

Mundipharma

Nanjing Medical University

Nanjing University

NanoCarrier Co., Ltd.

NantCell, Inc.

NantWorks

National Cancer Center, Korea

National Cancer Institute, France

National Comprehensive Cancer Network

National Institute of Cancerología

National Pediatric Cancer Foundation

National Taiwan University

National University of Singapore

Navidea Biopharmaceuticals

Neuroblastoma and Medulloblastoma Translational Research Consortium

New York Medical College

Ningbo No. 2 Hospital

NKMAX Co., Ltd.

Northwestern University

Oncolytics Biotech

Oncurious NV

Onxeo

Oregon Health and Science University

Osaka University

Otsuka

Pennsylvania State University

Peter MacCallum Cancer Centre

Petrov Research Institute of Oncology

Pharmacyclics

Plexxikon

Polaris Pharmaceuticals, Inc.

Premiere Oncology

PTC Therapeutics

Queen's University, Belfast

Radiation Therapy Oncology Group

Rafael Pharmaceuticals Inc.

RedHill Biopharma

Richard Scowcroft Foundation

Robert Roessle Klinik

Roche

Royal Liverpool & Broadgreen University Hospitals NHS Truts

Royal Marsden Hospital NHS Trust

Rutledge Cancer Foundation

Sarcoma Oncology Research Center, LLC

Schering-Plough

Seoul National University

Sheffield Hallam University

Shenzhen Geno-Immune Medical Institute

Shenzhen Hank Bioengineering Institute

Shenzhen University

Shin Kong Wu Ho-Su Memorial Hospital

Spectrum Pharmaceuticals

Stand Up To Cancer

Stanford University

St. Baldrick's Foundation

St. Jude Children's Hospital

Sugen

Sungkyunkwan University

Sun Yat-Sen University

Synta Pharmaceuticals Corp.

Taichung Veterans General Hospital

Taipei Veteran General hospital

Takara Bio Inc.

Tel Aviv University

Temple University

Tesaro

The EMMES Corporation

Thermo Fisher Scientific

The University of Texas, Dallas

Thomas Jefferson University

Tianjin Medical University

Tracon Pharmaceuticals Inc.

Tyme, Inc

Tzu Chi University

UNICANCER

Universidad Autonoma de Barcelona

Universidad Complutense de Madrid

Universitaetsklinikum Schleswig-Holstein

University of Alberta

University of Arizona

University of Arkansas

University of Barcelona

University of Birmingham

University of Bologna

University of Caen-Normandie

University of California, Davis

University of California, Los Angeles

University of Cambridge

University of Chicago

University of Copenhagen

University of Duisburg-Essen

University of Florida

University of Glasgow

University of Greifswald

University of Groningen

University of Heidelberg

University of Iowa

University of Kentucky

University of Lausanne

University of Lille

University of Malaga

University of Mannheim

University of New Mexico

University of Nice Sophia Antipolis

University of Ottawa

University of Oxford

University of Pittsburgh

University of Rochester

University of Santiago

University of Seville

University of South Carolina

University of South Florida

University of Sussex

University of Tennessee

University of Toronto

University of Ulsan

University of Utah

University of Valencia

University of Vermont

University of Virginia

University of Western Australia

University of Wisconsin

University of Zaragoza

Vasgene Therapeutics, Inc

Wake Forest University

Washington University in St. Louis

Wyeth

Yonsei University

Zhejiang University

Organization Involved with Phase 1 Indications (68)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.